Page last updated: 2024-11-03

trimopam and Lesch-Nyhan Syndrome

trimopam has been researched along with Lesch-Nyhan Syndrome in 1 studies

trimopam: RN given refers to parent cpd with unspecified isomeric designation; structure

Lesch-Nyhan Syndrome: An inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE. Affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures. Self-destructive behaviors such as biting of fingers and lips are seen frequently. Intellectual impairment may also occur but is typically not severe. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis. (Menkes, Textbook of Child Neurology, 5th ed, pp127)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breese, GR1
Criswell, HE1
Mueller, RA1

Reviews

1 review available for trimopam and Lesch-Nyhan Syndrome

ArticleYear
Evidence that lack of brain dopamine during development can increase the susceptibility for aggression and self-injurious behavior by influencing D1-dopamine receptor function.
    Progress in neuro-psychopharmacology & biological psychiatry, 1990, Volume: 14 Suppl

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aggression; Animals; Anti-Anxiety Agents

1990